mRNA ratios in urinary sediments and/ or urine as a prognostic and/or theranostic marker for prostate cancer

Details for Australian Patent Application No. 2005318369 (hide)

Owner Stichting, Katholieke Universiteit, The University Medical Centre Nijmegen

Inventors Verhaegh, Gerald; Witjes, Alfred J.; Schalken, Jack A.; Hessels, Daphne

Agent Pizzeys

Pub. Number AU-B-2005318369

PCT Pub. Number WO2006/066965

Priority 60/719,557 23.09.05 US; 2,491,067 24.12.04 CA

Filing date 23 December 2005

Wipo publication date 29 June 2006

Acceptance publication date 9 February 2012

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

31 May 2007 PCT application entered the National Phase

  PCT publication WO2006/066965 Priority application(s): WO2006/066965

9 February 2012 Application Accepted

  Published as AU-B-2005318369

7 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005318372-Pyridine compounds for the treatment of prostaglandin mediated diseases

2005318365-Solid pharmaceutical composition comprising valsartan